11/27/24 16:08 | 11/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 858 | D | | | | | | | | | | | | | | |
11/27/24 16:06 | 11/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 8 | 126 | D | | | | | | | | | | | | | | |
9/12/24 18:13 | 8/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 833 | D | | | | | | | | | | | | | | |
9/12/24 18:10 | 8/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 8 | 117 | D | | | | | | | | | | | | | | |
5/29/24 19:12 | 5/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 9 | 108 | D | | | | | | | | | | | | | | |
5/29/24 19:07 | 5/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 808 | D | | | | | | | | | | | | | | |
2/27/24 19:58 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 783 | D | | | | | | | | | | | | | | |
2/27/24 19:56 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 10 | 99 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 102 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/27/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.7322 | 0 | -3 | -3 | 102 | D | | | | | | | | | | | | | | |
12/4/23 16:54 | 11/30/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rothera Mark | CA | DO | P,CEO | P.m | 49 | 0.4936 | 0 | 100 | New | 100 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.5000 | 0 | -4 | -4 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:03 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 757 | D | | | | | | | | | | | | | | |
11/28/23 19:01 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 11 | 90 | D | | | | | | | | | | | | | | |
8/29/23 18:52 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 732 | D | | | | | | | | | | | | | | |
8/29/23 18:49 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 12 | 81 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 96 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.45 | 0 | -4 | -4 | 96 | D | | | | | | | | | | | | | | |
5/26/23 19:32 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 707 | D | | | | | | | | | | | | | | |
5/26/23 19:30 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 92 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.42 | 0 | -4 | -4 | 92 | D | | | | | | | | | | | | | | |
2/28/23 18:30 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 682 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 9 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.68 | 0 | -2 | -4 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:25 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 17 | 63 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 89 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -6 | 1.68 | 0 | -4 | -4 | 89 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -10 | 2.72 | 0 | -4 | -4 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -6 | 2.72 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:21 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 20 | 54 | D | | | | | | | | | | | | | | |
11/29/22 17:18 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 657 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -9 | 4.01 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:16 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -15 | 4.02 | 0 | -4 | -4 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 631 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -54 | 4.01 | 0 | -13 | -2 | 631 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -25 | 1.90 | 0 | -13 | -2 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.90 | 0 | -2 | -5 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 79 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -7 | 1.90 | 0 | -4 | -4 | 79 | D | | | | | | | | | | | | | | |